menu search

PKI / PerkinElmer, Inc. (PKI) CEO Prahlad Singh on Q1 2022 Results - Earnings Call Transcript

PerkinElmer, Inc. (PKI) CEO Prahlad Singh on Q1 2022 Results - Earnings Call Transcript
PerkinElmer, Inc. (NYSE:PKI ) Q1 2022 Earnings Conference Call May 3, 2022 5:00 PM ET Company Participants Stephen Willoughby - Vice President of Investor Relations Prahlad Singh - President and Chief Executive Officer Jamey Mock - Senior Vice President and Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore Mike Ryskin - Bank of America Daniel Macek - Stifel Josh Waldman - Cleveland Research Catherine Schulte - Baird Jack Meehan - Nephron Research Brandon Couillard - Jefferies Rachel Vatnsdal - JPMorgan Paul Knight - KeyBanc Patrick Donnelly - Citi Matt Sykes - Goldman Sachs Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. Read More
Posted: May 3 2022, 22:07
Author Name: Seeking Alpha
Views: 102468

PKI News  

PerkinElmer (PKI) Q1 Earnings Surpass Estimates

By Zacks Investment Research
May 11, 2023

PerkinElmer (PKI) Q1 Earnings Surpass Estimates

PerkinElmer (PKI) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earni more_horizontal

Is a Surprise Coming for Revvity (PKI) This Earnings Season?

By Zacks Investment Research
May 10, 2023

Is a Surprise Coming for Revvity (PKI) This Earnings Season?

Revvity (PKI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. more_horizontal

Revvity (PKI) to Report Q1 Earnings: Is a Beat in the Cards?

By Zacks Investment Research
May 8, 2023

Revvity (PKI) to Report Q1 Earnings: Is a Beat in the Cards?

Revvity's (PKI) first-quarter results are likely to reflect weak performance at the Diagnostics segment, partially offset by strong demand for Life Sc more_horizontal

PerkinElmer (PKI) Completes Divestment, New Business Name in Q2

By Zacks Investment Research
March 14, 2023

PerkinElmer (PKI) Completes Divestment, New Business Name in Q2

PerkinElmer (PKI) completes separation of its businesses into two entities ??? the AES business, and the Life Sciences and Diagnostics business. more_horizontal

PerkinElmer's (PKI) Q4 Earnings Top, Revenues Decline Y/Y

By Zacks Investment Research
February 14, 2023

PerkinElmer's (PKI) Q4 Earnings Top, Revenues Decline Y/Y

PerkinElmer's (PKI) fourth-quarter results benefit from the solid performance of the Discover & Analytics Solutions business, more than offset by lowe more_horizontal

PerkinElmer, Inc. (PKI) Q4 2022 Earnings Call Transcript

By Seeking Alpha
February 14, 2023

PerkinElmer, Inc. (PKI) Q4 2022 Earnings Call Transcript

PerkinElmer, Inc. (NYSE:PKI ) Q4 2022 Earnings Conference Call February 14, 2023 8:00 AM ET Company Participants Steve Willoughby - SVP, IR Prahlad Si more_horizontal

PerkinElmer (PKI) Beats Q4 Earnings and Revenue Estimates

By Zacks Investment Research
February 14, 2023

PerkinElmer (PKI) Beats Q4 Earnings and Revenue Estimates

PerkinElmer (PKI) delivered earnings and revenue surprises of 2.41% and 1.97%, respectively, for the quarter ended December 2022. Do the numbers hold more_horizontal

PerkinElmer: Capital Budgeting A Key Factor To The Investment Debate

By Seeking Alpha
January 31, 2023

PerkinElmer: Capital Budgeting A Key Factor To The Investment Debate

PerkinElmer continues to offer long-term upside potential with its management of capital and acquisitions. The economic value of its transactions has more_horizontal


Search within

Pages Search Results: